Gabor M. Kovacs
Budapest, BU 1142, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Unlocking the benefits of allopurinol: the role of timely initiation and adherence in cardiovascular and renal outcomes in hyperuricemia.
Journal: European journal of internal medicine
Published: January 22, 2026
Characterizing solute transport across cell layers: Artifact correction and parameter extraction from a simplified three-compartment model.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: August 27, 2025
Incorporating diagnostic testing into economic evaluations of tumour-agnostic therapies.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 08, 2025
Epidemiology of Hyperphenylalaninemia: A Systematic Review and Meta-Analysis.
Journal: Sage open pediatrics
Published: July 02, 2025
The value of metabolic surgery for patients with obesity and type 2 diabetes in Romania.
Journal: Frontiers in nutrition
Published: May 07, 2025
Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis.
Journal: Journal of hypertension
Published: June 11, 2024
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young.
Journal: Personalized medicine
Published: September 11, 2023
Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes.
Journal: Journal of diabetes research
Published: November 16, 2022
PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
Journal: British journal of cancer
Published: September 20, 2022
Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study.
Journal: BMC endocrine disorders
Published: May 30, 2022
Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 22, 2021
Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 23, 2019
Last Updated: 09/26/2026